News
How much could the Zantac lawsuits cost?
Last month, analysts at Shore Capital estimated that GSK shares had already priced in costs of up to $30 billion
4 Minute
September 20, 2024
Last month, analysts at Shore Capital estimated that GSK shares had already priced in costs of up to $30 billion